Showing results (51-60 of 201) with videos related to
Sort By:
Pageof 21
Drugs in Context|November 5, 2025
Place in therapy of key treatments for platinum-sensitive, relapsed, extensive-stage small cell lung cancer with a focus on lurbinectedin: a narrative review with case studiesLeonid Shunyakov, Firas B Badin, Judith Hafer, et al.Translational Cancer Research|January 16, 2025
IRF5 as a potential immunological biomarker in lung adenocarcinomaSimei Li, Fangling Zhou, Huahong Lan, et al.Ebiomedicine|May 27, 2023
Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancerFrançois Ghiringhelli, Frederic Bibeau, Laurent Greillier, et al.Clinical Lung Cancer|January 12, 2008
Pulmonary function tests as a predictor of quantitative and qualitative outcomes after thoracic surgery for lung cancerLaurent Greillier, Pascal Thomas, Anderson Loundou, et al.Respiration; International Review of Thoracic Diseases|March 20, 2004
Vascular stenting for palliation of superior vena cava obstruction in non-small-cell lung cancer patients: a future 'standard' procedure?Laurent Greillier, Fabrice Barlési, Christophe Doddoli, et al.Journal of Geriatric Oncology|May 19, 2022
Acceptance, efficacy, and safety of COVID-19 vaccination in older patients with cancerAnne-Laure Couderc, Laetitia Ninove, Emilie Nouguerède, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 20, 2024
Antibody-Drug Conjugates as Novel Therapeutic Agents for Non-Small Cell Lung Carcinoma with or without Alterations in Oncogenic DriversLaura Bender Somme, Christos Chouaid, Fabien Moinard-Butot, et al.Cancer|September 22, 2007
Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesotheliomaLaurent Greillier, Arnaud Cavailles, Anne Fraticelli, et al.Lung Cancer (Amsterdam, Netherlands)|October 5, 2020
Application of clinical trial inclusion criteria to clinical practice patients to quantify the burden of CNS metastases on health-related quality of life and healthcare resource use in patients with NSCLCGracy Crane, Vlatka Smoljanovic, Nasreen Khan, et al.European Journal of Cancer (Oxford, England : 1990)|February 21, 2023
Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018Olivier Bylicki, Pascale Tomasini, Gervais Radj, et al.Pageof 21